Services
Corporate, Portfolio & Growth Strategy
Scimitar helps life sciences companies unlock growth by shaping corporate strategy, strengthening portfolios, and accelerating organizational performance. We drive clarity in vision, optimize resource and pipeline decisions, and build high-performing teams to enable smarter, faster, and more confident execution.
Services We Deliver
Leadership & Team Coaching
Transform your organization through purpose, process, and presence – a human-focused approach to work smarter, align faster, and deliver with greater impact.
Portfolio &
Pipeline
Drive a clear alignment on a pipeline vision,
with proven models to optimize resources, incorporate collaborative inputs and AI/ ML intelligence, and tie pipeline scenarios to clear resourcing implications.
Human Capital, Workforce Planning & Optimization
Build high-performing organizations – aligning long-term workforce strategy, demand forecasting, and agile resource allocation to create an integrated planning engine the drives optimal organizational performance.
Mergers & Acquisitions
Empower life sciences growth through strategic M&A – integrating scientific insights, market intelligence, and operational excellence to unlock value, accelerate innovation, and strengthen portfolios from discovery to delivery.
Strategic Partnerships & Alliances
Identify the optimal strategic partnerships – whether CROs, CMOs or digital/AI partners. Our deep understanding of the marketplace and key success factors helps to ensure the right partners are identified, with the right terms and incentives to set you up for success.
Global Procurement Optimization
Optimize procurement and sourcing operations to drive cost efficiency, governance maturity, and cross-functional excellence through tailored org design and performance frameworks.
Interim CxO and Leadership Support
Empower life sciences organizations to navigate transitions and leadership gaps with seasoned Interim CxO expertise – providing immediate stability, strategic continuity, and high-impact leadership to maintain momentum in clinical development, commercialization, and corporate scaling.